Algiecel A/S: Financial statements 2022
CVR: 42394416
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Algiecel A/S (CVR 42394416) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,188,973 and a net result of DKK -6,697,004. Equity in the 2022 report amounted to DKK -1,379,532. The company had 4 employees in the financial year.
- Gross Profit
- DKK -6,188,973
- Profit/Loss
- DKK -6,697,004
- Equity
- DKK -1,379,532
- Total Assets
- DKK 5,645,026
- Employees
- 4
Official annual report
Keep an eye on Algiecel A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Algiecel A/S has published its interim report for the period May 17, 2021 – December 31, 2021.
About Algiecel A/S
Algiecel A/S is a Danish company of the type Aktieselskab based in Odense M, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Algiecel ApS. The management consists of Susanne Palsten Buchardt. The board consists of Tove Feld (chair), Henrik Busch-Larsen, Jeppe Høier and Martin Lavesen. The company is owned by HBL INVEST ApS, Danmarks Eksport- og Investeringsfond and AURELIUS LIMITED. According to the 2025 annual report, the company had an average of 13 employees. In 2025, the company reported a gross profit of DKK -10,788,792 and a net result of DKK -16,685,596 compared with DKK -12,002,459 the year before. Equity in the 2025 report amounted to DKK 29,209,580.